Open AccessHigh Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
Author(s) -
Veysel Haksöyler,
Erkan Topkan
Publication year - 2021
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s320145
Subject(s) - medicine , nasopharyngeal carcinoma , receiver operating characteristic , gastroenterology , multivariate analysis , chemoradiotherapy , cutoff , retrospective cohort study , area under the curve , oncology , surgery , overall survival , radiation therapy , physics , quantum mechanics
In a lack of similar research, we assessed the prognostic utility of pretreatment platelet-to-albumin ratio (PAR) in locally advanced nasopharyngeal carcinoma (LANPC) patients managed with concurrent chemoradiotherapy (CCRT).